Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system can be broadly activated by pathogens through molecular mimicry, where pathogen-derived molecules share structural or sequence similarities with host molecules. This cross-reactivity can lead to immune evasion by the pathogen and, in some cases, trigger autoimmune diseases. While molecular mimicry expands antigen recognition capacity, it also increases the risk of collateral damage via autoimmunity if tolerance mechanisms fail.
N/A (This is a biological process, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Broad Activation via Pathogen Mimicry) (N/A).